BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25497430)

  • 1. New insight into the aetiology of testicular germ cell tumours.
    Huddart R
    Eur Urol; 2015 Apr; 67(4):702-3. PubMed ID: 25497430
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
    van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
    Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell cancer risk in DSD patients.
    Cools M
    Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal tumours and DSD.
    Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible presence of an embryonal carcinoma-associated proteoglycan in the serum of patients with testicular germ cell tumours.
    Mason MD; Pera MF; Cooper S
    Eur J Cancer; 1991; 27(3):300. PubMed ID: 1851027
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor risk in disorders of sex development.
    Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
    Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Clinical Applications of Testicular Cancer Biomarkers.
    Mir MC; Pavan N; Gonzalgo ML
    Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus statement on circulating tumour markers and staging patients with germ cell tumours.
    Rustin GJ; Vogelzang NJ; Sleijfer DT; Nisselbaum JN
    Prog Clin Biol Res; 1990; 357():277-84. PubMed ID: 2170994
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor risk and clinical follow-up in patients with disorders of sex development.
    Cools M; Looijenga LH
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of Trace Elements in Patients with Testicular Cancers.
    Kaba M; Pirinççi N; Yüksel MB; Gecit İ; Güneş M; Demir M; Akkoyun H; Demir H
    Int Braz J Urol; 2015; 41(6):1101-7. PubMed ID: 26742967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of serum tumour marker monitoring.
    Colls BM
    Br J Cancer; 1991 Apr; 63(4):648. PubMed ID: 1850614
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumors of dysgenetic gonads in intersexes: case reports and discussion regarding their place in gonadal oncology.
    Melicow MM
    Bull N Y Acad Med; 1966 Jan; 42(1):3-20. PubMed ID: 5215586
    [No Abstract]   [Full Text] [Related]  

  • 13. The biology of germ cell tumors in disorders of sex development.
    Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
    Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in molecular markers of germ cell cancer in patients with disorders of sex development.
    van der Zwan YG; Cools M; Looijenga LH
    Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA19-9: a possible serum marker for embryonal carcinoma.
    Tsuruta T; Ogawa A; Ishii K; Ikado S
    Urol Int; 1997; 58(1):20-4. PubMed ID: 9058515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
    Rijlaarsdam MA; van Agthoven T; Gillis AJ; Patel S; Hayashibara K; Lee KY; Looijenga LH
    Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell tumours: a scary presentation.
    Oliveira CAB; Costa AC; Mendes V
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32699054
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors in metastatic disease.
    Droz JP; Kramar A; Rey A
    Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology and Diagnosis of Testis Cancer.
    Stevenson SM; Lowrance WT
    Urol Clin North Am; 2015 Aug; 42(3):269-75. PubMed ID: 26216814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.